Navigation Links
Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
Date:7/3/2012

Dallas, TX (PRWEB) July 03, 2012

The Pradaxa Resource Center, a patient advocacy group, is alerting patients who have taken or may be prescribed the drug Pradaxa that the maker of the drug is working on an antidote to help prevent potential deadly internal bleeding problems associated with Pradaxa.

The move comes as the FDA, European Medicines Agency and Institute for Safe Medication Practices have all warned that Pradaxa may cause serious or fatal internal bleeding of the intestines or brain, and a Federal Court is set to consolidate lawsuits filed by victims so far.

Anyone who has suffered a bleeding episode or lost a loved one after Pradaxa use is urged to speak with a lawyer about their legal rights as soon as possible.

Pradaxa is a popular anticoagulant prescribed to patients suffering from atrial fibrillation in order to prevent strokes. According to The Wall Street Journal on April 24, 2012, the drug reached blockbuster status after sales of $1 billion for the 12-month period ending in February.

Unfortunately, the FDA warned on December 7, 2011 that it was investigating the safety of Pradaxa after receiving higher than expected reports of injury or death. On May 25th, the European Medicines Agency also issued a warning on internal bleeding risks.

On June 6th, the Philadelphia Inquirer reported that Pradaxa led all other medications in 2011 for number of deaths and internal bleeding episodes reported to the FDA. The paper cited a report from the Institute for Safe Medication Practices' QuarterWatch program, which tracks reports to the FDA’s MedWatch.

Although all anticoagulants carry a risk of internal bleeding, most have a reversal agent available to doctors in emergency. A March 6, 2012 report by the Journal of Neurosurgery highlighted concerns from doctors that once Pradaxa causes internal bleeding in a patient, there is little they can do to stop it.

Now, Reuter
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Approval of Safer Alternative to Pradaxa Delayed by FDA
2. Corporate Whistle Blower Center Now Urges Medical Device Insiders To Be A Whistleblower If They Can Prove The Device Maker Knew Of A Failure & Said Nothing=Huge Rewards
3. Law Firm Aggressively Litigating against Birth Control Makers for their Newer, but Allegedly Unsafer Products: Nuvaring, Yaz, BeYaz, Yasmin, Ocella, Gianvi
4. Pacemakers, Defibrillators Sources of Deadly Infections: Study
5. DotComSecrets Invites Professionals to Learn Great Tips On How to Make a Handsome Income By Working As Local Internet Marketing Consultants
6. Doctors cite concern for patients, colleagues top motives for working sick
7. Moffitt Cancer Center researchers working at frontiers of melanoma research
8. Specialized care by experienced teams cuts death and disability from bleeding brain aneurysms
9. Tragic San Diego Dog Attack Leaves One Infant Dead – California Dog Bite Attorneys Revive Pit Bull Warnings
10. Aim Skin Cancer Warnings at the Young, Too, Experts Say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Alliance Healthcare Foundation (AHF), a nonprofit organization which ... and underserved in San Diego and Imperial County, recently ... award, the Innovation Initiative (i2). , “Alliance Healthcare ... our Innovation Initiative Award,” AHF Executive Director Nancy Sasaki ... ambitious projects in the past with this award, and ...
(Date:3/26/2015)... 26, 2015 The American College of Traditional ... the topics of the DAOM Program as well as Marketing ... Webinar will be hosted by Dr. Carla Wilson, who will ... steps on how to prepare for the spring quarter. The ... March 27, April 1 and April 3. Attendees can log ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Xarelto ... forward nationwide, with the issuance of new court ... and Louisiana. According to an Order dated March ... established for Xarelto injury claims in the U.S. ... allow plaintiffs to file cases directly in the ...
(Date:3/26/2015)... 26, 2015 Behavioral Research Group, ... announced the release of BathroomMap® , a new ... access to public restrooms for travelers, especially those with ... BathroomMap does not facilitate a paid, social or crowdsourced ... and rate local establishments that have clean, available restrooms ...
(Date:3/26/2015)... Saving Moses is a global humanitarian ... needed but least available. As one of their staple ... in the Benguela province of Angola to treat babies ... visit to their clinics, staff employed the art of ... babies in a nation the The New York Times ...
Breaking Medicine News(10 mins):Health News:Applications Open for $1M Innovation Initiative Award from Alliance Healthcare Foundation 2Health News:ACTCM Announces Upcoming Webinars 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2
... 22 /PRNewswire-FirstCall/ - Hard To Treat Diseases (HTDS) ... Sanja Pekovic provided updates from a recent medical ... Gesellschaft - Nederlandse Anatomen Vereniging, Antwerpen, 27-30 March ... of recent positive testing being conducted related to ...
... CITY, Calif., April 22 AcelRx Pharmaceuticals, Inc. ... 2 clinical trial of ARX-02, a proprietary sublingual ... control. The primary objective of this multicenter, randomized, ... and efficacy of ARX-02 relative to placebo in ...
... oil given to professional football players has proven to ... study published in the January/February 2009 issue of ... oil supplement was administered to 36 professional football players ... volunteered to be randomly assigned to either the treatment ...
... http://www.AmberCourtAL.com ) reaffirms its commitment to seniors on Medicaid. New ... Living Concepts, revealed a history of evictions when residents depleted ... ... NY (PRWEB) April 22, 2009 -- Raphael Weiss, Managing Director ...
... of Driver Technology to Power Artificial Heart Presented at ISHLT ... ... (Vocus) April 22, 2009 -- On April 22-25, SynCardia Systems, ... introduced the new 12-lb Freedom™ discharge driver at the International ...
... a new online training program designed to help medical transcriptionists ... ... Springville, Utah (PRWEB) April 22, 2009--Career ... transcription industry, has released a new online training program designed ...
Cached Medicine News:Health News:Hard To Treat Diseases (HTDS) Slavica BioChem Update on Research Activities 2Health News:Hard To Treat Diseases (HTDS) Slavica BioChem Update on Research Activities 3Health News:AcelRx Announces Initiation of Phase 2 Cancer Breakthrough Pain Program 2Health News:New Study Shows Fish Oil Improves Cholesterol Levels in Professional Football Players 2Health News:Amber Court Assisted Living Communities Reaffirms Its Commitment To Seniors On Medicaid 2Health News:SynCardia Introduces New 12-lb Freedom Discharge Driver ,Designed to Provide Quality 'Lifestyle' for Total Artificial Heart Patients 2Health News:Career Step Launches New Credential Exam Training Program for Medical Transcription Industry 2
(Date:3/26/2015)... March 26, 2015 Huntington Memorial Hospital is ... perform transcatheter aortic valve replacement (TAVR), a minimally invasive ... revolutionary new way to replace an aortic valve without ... lung machine. The procedure is performed by ... Azhil ( Alex) Durairaj , MD, interventional cardiologist and ...
(Date:3/26/2015)... 2015 Cardiologists at Beaumont Hospital, ... commercial implant of a device recently approved by the ... fibrillation. The Watchman Left Atrial Appendage Closure implant is ... to reduce the risk of stroke. Atrial ... more than 5 million Americans. Twenty percent of all ...
(Date:3/26/2015)... , March 26, 2015 Over-the-counter ... average American consumer. However, a new survey of ... ailments from the common cold to diabetes, can ... The research, conducted by the Private Label Manufacturers ... over-the-counter healthcare products, including those essential for treatment ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3Consumers can keep over-the-counter medicine affordable by using store brands 2
... aureus and, Methicillin-Resistant Staphylococcus aureus from Positive ... BD Diagnostics, a segment,of BD (Becton, Dickinson and ... it,received clearance from the U.S. Food and Drug ... new assay is the first test available to,rapidly ...
... Dec. 27 Allos,Therapeutics, Inc. (Nasdaq: ALTH ... (DMC) has completed the pre-specified 65-patient,safety review of ... trial of,PDX (pralatrexate) in patients with relapsed or ... the trial continue per the,protocol. This interim assessment ...
Cached Medicine Technology:BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures 2BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures 3Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 2Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 3Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 4Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 5
Designed for the effective positioning of patients during spinal surgery, the frame gives the surgeon a remarkably simple and versatile surgical tool....
... Plus Radiolucent Wilson Frame delivers ... with a convenient and stable ... a flexed position for laminectomy, ... procedures. Made with carbon composites ...
Adjust-A-Tip cautery....
Low temp, micro fine tip, patented Aaron RAM cauteries....
Medicine Products: